Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: A single institution experience

Weina Chen, Nitin J. Karandikar, Robert W. McKenna, Steven H. Kroft

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Essentially all cases of precursor B-lymphoblastic leukemiaAymphoma (B-ALL) demonstrate multiple immunophenotypic aberrancies relative to normal maturing B-cell precursors (hematogones). The stability of these aberrancies has relevance to follow-up minimal residual disease analysis. We compared the immunophenotypes at diagnosis and relapse in 51 childhood and adult B-ALLs with flow cytometry (FC) using broad antibody panels. A total of 446 aberrancies were present at diagnosis (median, 9 per case; range, 2-14). All cases retained multiple aberrancies at relapse (median, 8 per case; range, 2-14). Antibody panels at relapse allowed assessment of 383 (85.9%) of the initial 446 aberrancies. Of these, 299 (78.1%) were persistent and 84 (21.9%) were lost at relapse. Overall, 73% of cases showed a loss of at least 1 aberrancy at relapse. However, new aberrancies were detected in 60% of cases. These findings suggest that FC is suitable for the detection of residual B-ALL, provided that follow-up studies are not too narrowly targeted.

Original languageEnglish (US)
Pages (from-to)39-46
Number of pages8
JournalAmerican Journal of Clinical Pathology
Volume127
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia
Recurrence
Flow Cytometry
B-Lymphoid Precursor Cells
Antibodies
Residual Neoplasm

Keywords

  • Flow cytometry
  • Immunophenotypic stability
  • Minimal residual disease
  • Precursor B-All
  • Precursor B-lymphoblastic leukemia/lymphoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma : A single institution experience. / Chen, Weina; Karandikar, Nitin J.; McKenna, Robert W.; Kroft, Steven H.

In: American Journal of Clinical Pathology, Vol. 127, No. 1, 01.2007, p. 39-46.

Research output: Contribution to journalArticle

@article{715b221ffc1443408ecf8c0f5c896dd2,
title = "Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: A single institution experience",
abstract = "Essentially all cases of precursor B-lymphoblastic leukemiaAymphoma (B-ALL) demonstrate multiple immunophenotypic aberrancies relative to normal maturing B-cell precursors (hematogones). The stability of these aberrancies has relevance to follow-up minimal residual disease analysis. We compared the immunophenotypes at diagnosis and relapse in 51 childhood and adult B-ALLs with flow cytometry (FC) using broad antibody panels. A total of 446 aberrancies were present at diagnosis (median, 9 per case; range, 2-14). All cases retained multiple aberrancies at relapse (median, 8 per case; range, 2-14). Antibody panels at relapse allowed assessment of 383 (85.9{\%}) of the initial 446 aberrancies. Of these, 299 (78.1{\%}) were persistent and 84 (21.9{\%}) were lost at relapse. Overall, 73{\%} of cases showed a loss of at least 1 aberrancy at relapse. However, new aberrancies were detected in 60{\%} of cases. These findings suggest that FC is suitable for the detection of residual B-ALL, provided that follow-up studies are not too narrowly targeted.",
keywords = "Flow cytometry, Immunophenotypic stability, Minimal residual disease, Precursor B-All, Precursor B-lymphoblastic leukemia/lymphoma",
author = "Weina Chen and Karandikar, {Nitin J.} and McKenna, {Robert W.} and Kroft, {Steven H.}",
year = "2007",
month = "1",
doi = "10.1309/7R6MU7R9YWJBY5V4",
language = "English (US)",
volume = "127",
pages = "39--46",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "1",

}

TY - JOUR

T1 - Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma

T2 - A single institution experience

AU - Chen, Weina

AU - Karandikar, Nitin J.

AU - McKenna, Robert W.

AU - Kroft, Steven H.

PY - 2007/1

Y1 - 2007/1

N2 - Essentially all cases of precursor B-lymphoblastic leukemiaAymphoma (B-ALL) demonstrate multiple immunophenotypic aberrancies relative to normal maturing B-cell precursors (hematogones). The stability of these aberrancies has relevance to follow-up minimal residual disease analysis. We compared the immunophenotypes at diagnosis and relapse in 51 childhood and adult B-ALLs with flow cytometry (FC) using broad antibody panels. A total of 446 aberrancies were present at diagnosis (median, 9 per case; range, 2-14). All cases retained multiple aberrancies at relapse (median, 8 per case; range, 2-14). Antibody panels at relapse allowed assessment of 383 (85.9%) of the initial 446 aberrancies. Of these, 299 (78.1%) were persistent and 84 (21.9%) were lost at relapse. Overall, 73% of cases showed a loss of at least 1 aberrancy at relapse. However, new aberrancies were detected in 60% of cases. These findings suggest that FC is suitable for the detection of residual B-ALL, provided that follow-up studies are not too narrowly targeted.

AB - Essentially all cases of precursor B-lymphoblastic leukemiaAymphoma (B-ALL) demonstrate multiple immunophenotypic aberrancies relative to normal maturing B-cell precursors (hematogones). The stability of these aberrancies has relevance to follow-up minimal residual disease analysis. We compared the immunophenotypes at diagnosis and relapse in 51 childhood and adult B-ALLs with flow cytometry (FC) using broad antibody panels. A total of 446 aberrancies were present at diagnosis (median, 9 per case; range, 2-14). All cases retained multiple aberrancies at relapse (median, 8 per case; range, 2-14). Antibody panels at relapse allowed assessment of 383 (85.9%) of the initial 446 aberrancies. Of these, 299 (78.1%) were persistent and 84 (21.9%) were lost at relapse. Overall, 73% of cases showed a loss of at least 1 aberrancy at relapse. However, new aberrancies were detected in 60% of cases. These findings suggest that FC is suitable for the detection of residual B-ALL, provided that follow-up studies are not too narrowly targeted.

KW - Flow cytometry

KW - Immunophenotypic stability

KW - Minimal residual disease

KW - Precursor B-All

KW - Precursor B-lymphoblastic leukemia/lymphoma

UR - http://www.scopus.com/inward/record.url?scp=34249077296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249077296&partnerID=8YFLogxK

U2 - 10.1309/7R6MU7R9YWJBY5V4

DO - 10.1309/7R6MU7R9YWJBY5V4

M3 - Article

C2 - 17145625

AN - SCOPUS:34249077296

VL - 127

SP - 39

EP - 46

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 1

ER -